Skip to main content

Table 3 Gene regions with correlation between methylation level and relapse-free survival in ALL

From: Genome-wide signatures of differential DNA methylation in pediatric acute lymphoblastic leukemia

ALL subtypea

Gene symbol

Gene name

Chromosome

Number of DMCsb

t(12;21)ETV6/RUNX1

ERVH-3

Endogenous retrovirus group H, member 3

6q12

11

 

C1orf222

Chromosome 1 open reading frame 222

1p36.33

2

 

KCNA3

Potassium voltage-gated channel, shaker-related subfamily, member 3

1p13.3

2

 

PAG1

Phosphoprotein associated with glycosphingolipid microdomains 1

8q21.13

2

 

DNMBP

Dynamin binding protein

10q24.31

2

 

C11orf52

Chromosome 11 open reading frame 52

11q23.1

2

MLL/11q23

ZSCAN18

Zinc finger and SCAN domain containing 18

19q13.43

4

 

ZNF544

Zinc finger protein 544

19q13.43

4

 

TAPBP/DAXX

TAP binding protein (tapasin)/death-domain associated protein

6p21.3

3

 

WT1

Wilms tumor 1

11p13

3

 

ZNF681

Zinc finger protein 681

19p12

3

 

ADARB2

Adenosine deaminase, RNA-specific, B2 (non-functional)

10p15.3

2

 

ZNF329

Zinc finger protein 329

19q13.31

2

 

ZNF526

Zinc finger protein 526

19q13.31

2

t(9;22)BCR/ABL1

LOC146880

Pri-miRNA; hsa-mir-6080 (ENSG00000215769)

17q24.1

2

  1. aBCP ALL cytogenetic subtypes with subtype-specific differentially methylated CpGs (DMCs) predictive of relapse (P < 0.1).
  2. bNumber of sites in the region associated with relapse-free survival (P <0.05).